BSA/polyelectrolyte core-shell nanoparticles for controlled release of encapsulated ibuprofen

Colloids and Surfaces B: Biointerfaces

Volumn 123, Issue , 2014, Pages 616-622

  Varga, N ^a   Benko, M ^b   Sebok, D ^b   Dekany I ^b,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Bovine serum albumin; Controlled release; Core shell nanoparticles; Ibuprofen; Kinetic models; Polyelectrolytes

Indexed keywords

BODY FLUIDS; DYNAMIC LIGHT SCATTERING; INFRARED IMAGING; KINETIC PARAMETERS; KINETIC THEORY; MAMMALS; NANOPARTICLES; POLYELECTROLYTES; PROTEINS; STYRENE; SURFACE PLASMON RESONANCE; X RAY SCATTERING;

BOVINE SERUM ALBUMINS; CONTROLLED RELEASE; CORE-SHELL NANOPARTICLES; IBUPROFEN; KINETIC MODELS;

SHELLS (STRUCTURES);

BOVINE SERUM ALBUMIN; CHITOSAN; IBUPROFEN; NANOPARTICLE; POLY(SODIUM 4 STYRENE)SULFONATE; POLYELECTROLYTE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG SOLUBILITY; IN VITRO STUDY; NANOENCAPSULATION; PARTICLE SIZE; PH; ZETA POTENTIAL;

BOVINAE;

EID: 84915826053     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.10.005     Document Type: Article

References (38)

1. Takami A., Tatsuo K., Toshiyuki K., Mitsuru A. Preparation and characterization of biodegradable nanoparticles based on poly(g-glutamic acid) with l-phenylalanine as a protein carrier. J. Control. Release 2005, 108:226-236.
2. Danhier F., et al. PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release 2012, 161:505-522.
3. Lama P.L., Gambari R. Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries. J. Control. Release 2014, 178:25-45.
4. Sparnacci K., Laus M., Tondelli L., Magnani L., Bernardi C. Core-shell microspheres by dispersion polymerization as drug delivery systems. Macromol. Chem. Phys. 2002, 203:1364-1369.
5. Wang N., Ye L., Zhao B.Q., Yu J.X. Spectroscopic studies on the interaction of efonidipine with bovine serum albumin. Braz. J. Med. Biol. Res. 2008, 41:589-595.
6. Elzoghby A.O., Samy W.M., Elgindy N.A. Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Control. Release 2012, 157:168-182.
7. Kandagal P.B., et al. Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach. J. Pharm. Biomed. Anal. 2006, 41:393-399.
8. Purcell M., Neault J.F., Tajmir-Riahi H.A. Interaction of taxol with human serum albumin. Biochim. Biophys. Acta 2000, 1478:61-68.
9. Kragh-Hansen U., Chuang V.T., Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol. Pharm. Bull. 2002, 25:695-704.
10. Sudlow G., Birkett D.J., Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 1975, 11:824-832.
11. Jimenez M.C., Miranda M.A., Vaya I. Triplet excited states as chiral reporters for the binding of drugs to transport proteins. J. Am. Chem. Soc. 2005, 127:10134-10135.
12. Guharay J., Sengupta B., Sengupta P.K. Protein-flavonol interaction: fluorescence spectroscopic study. Proteins 2001, 43:75-81.
13. Brown J.R. Structural origins of mammalian albumin. Fed. Proc. 1976, 35:2141-2144.
14. Gelamo E.L., Silva C., Imasato H., Tabak M. Interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants: spectroscopy and modelling. Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 2002, 1594:84-99.
15. Kong J., Yu S. Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochim. Biophys. Sin. 2007, 39:549-559.
16. Wang T., Zhao Z., Wei B., Zhang L., Ji L. Spectroscopic investigations on the binding of dibazol to bovine serum albumin. J. Mol. Struct. 2010, 970:128-133.
17. Wang C.X., Yan F.F., Zhang Y.X., Ye L. Spectroscopic investigation of the interaction between rifabutin and bovine serum albumin. J. Photochem. Photobiol. A 2007, 192:23-28.
18. Cai H.H., et al. Probing site-selective binding of rhodamine B to bovine serum albumin. Colloids Surf., A: Physicochem. Eng. Aspects 2010, 372:35-40.
19. Kocbek P., Baumgartner S., Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int. J. Pharm. 2006, 312:179-186.
20. Sádecká J., Cakrt M., Hercegová A., Polonský J., Skacáni I. Determination of ibuprofen and naproxen in tablets. J. Pharm. Biomed. Anal. 2001, 25:881-891.
21. Flanagan R.J. Guidelines the interpretation of analytical toxicology results and unit of measurement conversion factors. Ann. Clin. Biochem. 1998, 35:261-265.
22. Tsume Y., et al. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen. Biopharm. Drug Dispos. 2012, 33:366-377.
23. Ang W.S., Elimelech M. Protein (BSA) fouling of reverse osmosis membranes: implications for wastewater reclamation. J. Membr. Sci. 2007, 296:83-92.
24. Salonen J., et al. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control. Release 2005, 108:362-374.
25. Chitkara D., Kumar N. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs. Pharm. Res. 2013, 30:2396-2409.
26. Kim J.H., Taluja A., Knutson K., Bae Y.H. Stability of bovine serum albumin complexed with PEG-poly(l-histidine) diblock copolymer in PLGA microspheres. J. Control. Release 2005, 109:86-100.
27. Shoaib M.H., et al. Development and evaluation of hydrophilic colloid matrix of famotidine tablets. AAPS PharmSciTech 2010, 2:708-718.
28. Kun R., Kis L., Dékány I. Hydrophobization of bovine serum albumin with cationic surfactants with different hydrophobic chain length. Colloids Surf., B: Biointerfaces 2010, 79:61-68.
29. Steinhilber D., et al. Surfactant free preparation of biodegradable dendritic polyglycerol nanogels by inverse nanoprecipitation for encapsulation and release of pharmaceutical biomacromolecules. J. Control. Release 2013, 169:289-295.
30. Fu K., et al. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. J. Control. Release 1999, 58:357-366.
31. Glatter O., Kratky O. Small Angle X-ray Scattering 1982, Academic Press, London.
32. Feigin L.A., Svergun D.I. Structure Analysis by Small-angle X-ray and Neutron Scattering 1987, Plenum Press, New York.
33. Svergun D.I. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 1992, 25:495-503.
34. Calvo P., Remufian C., Vila Jato J.L., Alonso M.J. Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron emulsions. Colloid Polym. Sci. 1997, 275:46-53.
35. Kreuter J., Alyautdin R.N., Kharkevich D.A., Ivanov A.A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain. Res. 1995, 674:171-174.
36. Xu H., et al. Characterization of the Interaction between eupatorin and bovine serum albumin by spectroscopic and molecular modeling methods. Int. J. Mol. Sci. 2013, 14:14185-14203.
37. Fasano M., et al. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 2005, 57:787-796.
38. Galantini L., et al. Human serum albumin binding ibuprofen: a 3D description of the unfolding pathway in urea. Biophys. Chem. 2010, 147:111-122.